{
  "pmid": "40677732",
  "title": "Bimekizumab for psoriasis treatment: A Canadian real-world multicenter study.",
  "abstract": "",
  "pub_date": "2025-06-06",
  "publication_types": [
    "Journal Article"
  ],
  "affiliations": [
    "Lovegrove Dermatology, London, Ontario, Canada.",
    "Department of Medicine, Schulich School of Medicine and Dentistry, London, Ontario, Canada.",
    "Origins Dermatology Centre, Regina, Saskatchewan, Canada.",
    "Maritime Dermatology, Halifax, Nova Scotia, Canada.",
    "Probity Medical Research, Waterloo, Ontario, Canada.",
    "Division of Dermatology, The Ottawa Hospital, Ottawa, Ontario, Canada.",
    "Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.",
    "West Ottawa Specialty Care, Ottawa, Ontario, Canada.",
    "Division of Dermatology and Rheumatology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.",
    "SKiN Health, Peterborough, Ontario, Canada.",
    "Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.",
    "Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.",
    "Probity Medical Research, Waterloo, Ontario, Canada.",
    "Division of Dermatology, Department of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.",
    "Walker Dermatology, Saskatoon, Saskatchewan, Canada.",
    "Probity Medical Research, Waterloo, Ontario, Canada.",
    "SKiN Health, Peterborough, Ontario, Canada.",
    "Queen's University, Kingston, Ontario, Canada."
  ],
  "url": "https://pubmed.ncbi.nlm.nih.gov/40677732/",
  "snapshot_id": "2026-02-12T15-12-29Z",
  "ingested_at": "2026-02-12T15:12:33.030557+00:00"
}